Staphylococcus aureus bacteremic pneumonia
- PMID: 26780692
- DOI: 10.1007/s10096-015-2566-8
Staphylococcus aureus bacteremic pneumonia
Abstract
Staphylococcus aureus bacteremic pneumonia is an uncommon cause of hospitalization, with a high mortality rate. However, published reports are scarce and have included a small number of cases. All patients with S. aureus bacteremic pneumonia were prospectively collected in our institution from 2000 to 2014, and a retrospective revision was performed to identify risk factors associated with methicillin resistance and to update the mortality of this entity. A total of 98 patients were admitted: 57.1 % were due to methicillin-susceptible S. aureus (MSSA) and 42.8 % due to methicillin-resistant S. aureus (MRSA). In 40 patients (40.8 %), the infection was community acquired. Thirteen were ventilator-associated pneumonia episodes. The most frequent comorbidities were chronic lung disease (34.7 %), chronic renal failure (31.6 %), diabetes mellitus (29.6 %), and cardiovascular disease (31.6 %). Septic shock was present in 46 patients (46.9 %). The 30-day mortality was 46.9 %. MRSA infections occurred in older patients, more frequently with cardiovascular diseases, and they had received antibiotic treatment in the previous month more often than MSSA-infected patients. Patients with infection due to MSSA presented more frequently with septic shock, but they received more frequently appropriate empirical antibiotic therapy than patients with MRSA pneumonia (96 % vs. 38.1 %), and no differences in mortality were observed between both groups. In conclusion, S. aureus bacteremic pneumonia is a severe infection that, nowadays, affects people with comorbidities and the mortality is still high.
Similar articles
-
Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1545-9. doi: 10.1164/ajrccm.150.6.7952612. Am J Respir Crit Care Med. 1994. PMID: 7952612
-
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms.Clin Infect Dis. 1999 Nov;29(5):1171-7. doi: 10.1086/313440. Clin Infect Dis. 1999. PMID: 10524959
-
Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.Crit Care. 2015 Sep 3;19(1):312. doi: 10.1186/s13054-015-1029-z. Crit Care. 2015. PMID: 26335247 Free PMC article.
-
Comparison of community-acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine leukocidin.Int J Tuberc Lung Dis. 2009 Dec;13(12):1476-85. Int J Tuberc Lung Dis. 2009. PMID: 19919764 Review.
-
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.Clin Microbiol Infect. 2014 Apr;20 Suppl 4:19-36. doi: 10.1111/1469-0691.12450. Clin Microbiol Infect. 2014. PMID: 24580739 Review.
Cited by
-
A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?Medicine (Baltimore). 2016 Aug;95(35):e4708. doi: 10.1097/MD.0000000000004708. Medicine (Baltimore). 2016. PMID: 27583907 Free PMC article.
-
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.PLoS One. 2017 Sep 5;12(9):e0183457. doi: 10.1371/journal.pone.0183457. eCollection 2017. PLoS One. 2017. PMID: 28873428 Free PMC article.
-
ROS-Driven Nanoventilator for MRSA-Induced Acute Lung Injury Treatment via In Situ Oxygen Supply, Anti-Inflammation and Immunomodulation.Adv Sci (Weinh). 2025 May;12(18):e2406060. doi: 10.1002/advs.202406060. Epub 2025 Mar 19. Adv Sci (Weinh). 2025. PMID: 40106334 Free PMC article.
-
Clinical characteristics of and risk factors for secondary bloodstream infection after pneumonia among patients infected with methicillin-resistant Staphylococcus aureus.Heliyon. 2022 Dec 2;8(12):e11978. doi: 10.1016/j.heliyon.2022.e11978. eCollection 2022 Dec. Heliyon. 2022. PMID: 36506352 Free PMC article.
-
Experimental Study on the Resistance of Synthetic Penicillin Solid Lipid Nanoparticles to Clinically Resistant Staphylococcus aureus.Comput Math Methods Med. 2021 Nov 11;2021:9571286. doi: 10.1155/2021/9571286. eCollection 2021. Comput Math Methods Med. 2021. PMID: 34804197 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources